Antiviral Drug May Prevent Ebola, Small Study Suggests

Health care workers deemed at high risk for infection didn't get sick after treatment with anti-flu regimen

CLICK HERE - The Lancet - Post-exposure prophylaxis against Ebola virus disease with experimental antiviral agents: a case-series of health-care workers

nlm.nih.gov - by Robert Preidt - August 25, 2015

Antiviral drugs may help protect people from developing Ebola after exposure to the deadly virus, a new case study suggests.

"We are excited to publish the first report of an antiviral-based post-exposure treatment against Ebola-virus infection in humans. We believe this work justifies further study of this postexposure treatment to protect health care workers accidentally exposed to Ebola virus in the field," lead author Dr. Michael Jacobs, of the Royal Free NHS Foundation Trust, London, said in a news release from The Lancet Infectious Diseases.

"What is more, a similar approach to treat household contacts of Ebola cases may work to prevent a major route of spread during an epidemic," he added.

(READ COMPLETE ARTICLE)

(ALSO SEE RELATED ARTICLE HERE)

CLICK HERE - The Lancet Infectious Diseases: Experimental post-exposure antiviral treatment may protect humans from Ebola virus